Uploaded June 2023 | Updated November 2026, 4 days ago
In this panel at Ending Age-Related Diseases 2022, Nathan Cheng of the Longevity Biotech Fellowship, Miri Polachek of Quadrascope, Laurence Ion of VitaDAO, Juliette Han of Cambrian Biopharma, and Alexandra Bause of Apollo Health Ventures come together to discuss the ways in which investment capital flows into the longevity biotech space. The panelists discuss the concentration of capital in specific companies and geographical areas along with the long-term viability of biotechnology accelerators.
FOLLOW US
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
lifespan.io
facebook.com/lifespanio
instagram.com/lifespan.io
HOW CAN YOU SUPPORT US?
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Lifespan.io, a 501(c)(3) nonprofit organization.
► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero
► Subscribe: youtube.com/user/LifespanIO
► Learn more, and help us: lifespan.io
#longevity #biotech #investment
In this panel at Ending Age-Related Diseases 2022, Nathan Cheng of the Longevity Biotech Fellowship, Miri Polachek of Quadrascope, Laurence Ion of VitaDAO, Juliette Han of Cambrian Biopharma, and Alexandra Bause of Apollo Health Ventures come together to discuss the ways in which investment capital flows into the longevity biotech space. The panelists discuss the concentration of capital in specific companies and geographical areas along with the long-term viability of biotechnology accelerators.
FOLLOW US
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
lifespan.io
facebook.com/lifespanio
instagram.com/lifespan.io
HOW CAN YOU SUPPORT US?
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Lifespan.io, a 501(c)(3) nonprofit organization.
► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero
► Subscribe: youtube.com/user/LifespanIO
► Learn more, and help us: lifespan.io
#longevity #biotech #investment










